Predictive Effect of IGFBP-3 on Low-Dose Tamoxifen Efficacy in Noninvasive Breast Cancer in the Phase III Tam-01 Trial.
Johansson H, Macis D, Oliva M, Puntoni M, Blondeaux E, Guerrieri-Gonzaga A, Aristarco V, Briata IM, Buttiron-Webber T, Boni L, Lazzeroni M, Serrano D, Giordano L, Digennaro M, Cortesi L, Millo F, Cagossi K, Aprile G, Falcini F, Gallerani E, Bonanni B, DeCensi A.
Johansson H, et al. Among authors: digennaro m.
Clin Cancer Res. 2025 May 15;31(10):1841-1846. doi: 10.1158/1078-0432.CCR-24-2987.
Clin Cancer Res. 2025.
PMID: 40293268
Clinical Trial.